This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 2025 AHA Statistical Update is the product of a full years worth of effort in 2024 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members.
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.
tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. From Research to Real-World Care 🌎 Understand how AI-driven advancements are shaping personalized treatments and patient outcomes. But its impact goes far beyond research.
In 2025, the world of healthcare is changing daily, and nowhere is this more apparent than in cardiology. For cardiology practices, choosing the right patient engagement platform is vital for improving outcomes, optimizing workflow, and maintaining a competitive edge.
tim.hodson Mon, 03/31/2025 - 15:39 March 30, 2025 Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Two-Year Outcomes of the Five-Year SMART Trial, presented at CRT 2025. Additional findings at five years include: Numerically lower rate of cardiovascular mortality (7.2%
Nature Reviews Cardiology, Published online: 20 January 2025; doi:10.1038/s41569-025-01118-1 The past 20 years have witnessed remarkable progress in the evolution of transcatheter procedures for the treatment of adult patients with congenital heart disease.
Thats why Cassling is excited to introduce a new awards program that recognizes and celebrates imaging teams contributions to keeping care local and improving patient outcomes. The company strives to bring innovative imaging solutions to communities and providers, so that patients and their families can live their best life.
The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients. The study addressed a critical question in cardiac surgery: how age and valve type influence outcomes for patients undergoing surgical AVR.
Event 2025 Advances in Quality & Outcomes: A Data Managers Meeting gmckinney Thu, 01/02/2025 - 11:08 Event dates Oct 13, 2025 Location San Antonio, TX AQO 2025 will offer a unique opportunity to explore techniques for optimizing data collection using case scenarios and driving quality improvement.
Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
We wanted to examine our outcomes, and we were pleasantly surprised to find that the freedom from re-intervention was 91% at 10 years and 87% at 20 years. Congenital All Members Clinical Decision-Making Patient Outcomes Quality Improvement The main drawback of the Ross operation is failure of the autograft over time, Dr. Shetty said.
tim.hodson Fri, 03/14/2025 - 11:42 March 11, 2025 CareDx, Inc. Now, we have a well-validated, non-invasive tool to monitor organ rejection and injury, which has the potential to improve their quality of life and long-term outcomes. "We Clin Transplant. 2024 Oct;38(10):e15481. doi: 10.1111/ctr.15481. Clin Transplant.
tim.hodson Wed, 03/26/2025 - 14:25 March 17, 2025 Bayer recently announcedthat the U.S. In fact, a 2024 report on heart failure trends and outcomes published in the Journal of Cardiac Failure showed that in patients with heart failure with preserved ejection fraction, 5-year mortality was 75.7%. Accessed February 21, 2025.
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in cardiac surgery.
Last month, the 2025 American Diabetes Association (ADA) guidelines were introduced, providing updates for diagnosing and managing diabetes and prediabetes. Explore the complete 2025 ADA Standards of Care in Diabetes to learn more about improving outcomes and care quality for individuals with diabetes.
They concluded, "Our findings increase confidence in the normal automated GE Marquette 12 SL ECG software interpretation to predict a benign outcome. Smith comment: this is a very stupid outcome measure) What if we use that methodology for the ECG above? What is the gold standard for ECG interpretation: patient outcome!!!
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in vascular surgery.
Publication date: Available online 24 January 2025 Source: The American Journal of Cardiology Author(s): Eric J. Hall, Colby R. Ayers, Nicholas S. Hendren, Christopher Clark, Amit Saha, Hadi Beaini, Isabella L. Alexander, Evan P. Gee, Ian R. McConnell, Emily S. Samson, Roslyn J. Saplicki, Christopher S. Grubb, Grant Tucker, Justin L.
tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., The Company anticipates initiating the trial in the first quarter of 2025. We believe suppression of aldosterone production by lorundrostat has the potential to reduce the nocturnal hypertension driving adverse cardiovascular outcomes.
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery.
tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25
tim.hodson Tue, 03/04/2025 - 14:11 Feb. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. Early detection through regular heart check-ups, including listening for murmurs, can lead to timely treatment and improved outcomes.
This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.
tim.hodson Mon, 01/06/2025 - 16:04 Jan. Harmony TPV system clinical trials demonstrate ease of implant, conformability to the anatomy, and strong clinical and hemodynamic outcomes for congenital heart disease patients up to three years. CE Mark follows U.S. Food and Drug Administration approval of the system in 2021. Harmony TPV U.S.
Publication date: Available online 20 January 2025 Source: The American Journal of Cardiology Author(s): Robert C. Stoler, Minseob Jeong, Talha Akram, Alec Monhollen, David Fernandez Vazquez, Mufaddal Mamawala, Trenton A. Witt, Blake Bruneman, Sarah Weideman, Kennedy S. Adelman, Shalini Sharma, Yumna Furqan, Zachary P.
tim.hodson Wed, 02/26/2025 - 10:24 Feb. 25, 2025 Heartflow, Inc. , A key element of Heartflows approach is close collaboration with clinical teams to improve patient experiences, create efficient care pathways and reach more patients with personalized insights, ensuring the best possible outcomes. In the U.S., Cleveland Clinic.
Inference Established that FFR-guided PCI is superior to angiography-guided PCI in multivessel CAD, reducing unnecessary revascularizations and improving outcomes. 5 years later in 2025 FAME 3 : 5 year follow up data , released in 2025, tries to confirm the non inferiorty of PCI over CABG in a larger sense. for PCI vs. 6.9%
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke.
tim.hodson Wed, 02/12/2025 - 15:04 Feb. 12, 2025 On Feb. 11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., This provides us with an opportunity to expand the use of this ablation energy across a much broader group of patients and capitalize on better outcomes, he said. The procedure performed by Dr.
Lilly’s blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity.
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). The company will further expand use of Volt in EU markets throughout the second half of 2025. AF Symposium 2025,Boston MA, USA.
2025 STS/EACTS/LACES Latin America Cardiovascular Surgery Conference Exhibitor Prospectus smccarthy Mon, 03/17/2025 - 10:41 Submit Your Application About the Conference The conference is a collaborative event hosted by STS, EACTS, and LACES, in partnership with the Sociedad Cientfica de Medicina Cardiovascular del Peru (SOCIMECAR).
David Luria (left), Director of Electrophysiology at Hadassah Medical Center, and Ziv Menshes (right), CEO of CardioVia tim.hodson Tue, 04/08/2025 - 14:38 April 7, 2025 CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S. According to expert estimates, millions of people in the U.S.
tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts.
17, 2025 DALLAS, Feb. 17, 2025 The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome measures. Embargoed until 4:00 a.m. CT/5:00 a.m. ET Monday, Feb.
tim.hodson Fri, 03/28/2025 - 15:23 Mar. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. For more information on Revolution Vibe, please visit gehealthcare.com.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content